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Sources and magnitude of error in preparing morphine infusions for nurse/patient 1 
controlled analgesia in a UK paediatric hospital 2 
 3 
 4 
Introduction  5 
Preparing infusions for administration to children requires complex dosage calculations, 6 
infusion rate adjustments and several manipulations; putting children at risk [1]. Wrong 7 
diluent or volume of infusion prepared, or wrong infusion rate administered are commonly 8 
reported, with incidence rates between 1.6% to 91.7% [1-2]. A previous UK study identified 9 
errors occurred in almost half of intravenous (IV) medicine preparations observed (49%, 10 
n=212/430), of which 1% of errors were severe and 29% were moderately severe [3]. 11 
Causes of such error include poor knowledge of correct methods for IV medicine preparation 12 
or administration and high workload [4]. Ten-fold or greater dose calculation errors have 13 
been reported through misplacement of the decimal point [5]. There is no standard 14 
preparation methods for these infusions and children have a 200 times difference in weight 15 
range (i.e. 0.5 - 100 kg) compared to 3 times in adults (i.e. 40 - 120 kg). 16 
 17 
In a system prone to the errors described above, there are high risk consequences if potent 18 
drugs such as opiates are not delivered accurately, i.e. respiratory depression in overdose.  19 
The calculations required to produce paediatric preparations increase the risk of error. 20 
Currently, nurse- and/or patient-controlled analgesia (N/PCA) for children are prepared as 21 
‘individually made products’, i.e. prepared for each patient based on their weight, using 22 
variations of the “rule of six” formula [6] to calculate the infusion concentrations prescribed in 23 
micrograms per kilogram per minute. This formula is described as: 6 x patient’s weight (kg) 24 
equals the amount of drug in milligrams that should be added to 100 mL of solution, when 25 
administered at 1 mL/h to give an infusion rate of 1 micrograms/kg/min [6]. 26 
 27 
Aim of the study 28 
2 
 
To investigate the current practice and accuracy of preparation of nurse/patient controlled 29 
analgesia N/PCA morphine infusions in theatres and wards at a large UK children’s hospital.  30 
 31 
Ethical Approval 32 
This study was approved by the Research and Development (R&D) department at Guy’s and 33 
St Thomas’ NHS Foundation Trust (GSTT) and categorised by the local NHS Research 34 
Ethics Committee as a non-Ethics study.  35 
 36 
Methods 37 
Setting 38 
This study was conducted at the Evelina London Children’s Hospital (ELCH). Morphine 39 
infusions for N/PCA are prepared in theatres and on wards individually for children based on 40 
a prescribed content of 1 mg/kg of morphine in a 50 mL solution.  41 
 42 
Design 43 
Direct observation of preparing and administering morphine for N/PCA in children by 44 
healthcare professionals (HCP), i.e. paediatric nurses and anaesthetists, was undertaken 45 
over three months. Observation was conducted by a single researcher (an experienced 46 
clinical pharmacist - ANR). The researcher explained the study and obtained permission 47 
from HCPs in theatres and wards to observe the preparation and administration process of 48 
morphine infusions for N/PCA. Data collected from direct observation included patient 49 
demographics (age, gender, weight) and morphine N/PCA prescription details. Data for the 50 
preparation and administration process included location; nurse or anaesthetist; infusion 51 
preparation procedure and infusion pump programming with delivery parameters (continuous 52 
infusion rate, bolus dose, lockout period between bolus doses). Syringe sizes used to draw 53 
up the morphine and diluent solution for the infusion preparation were recorded. Appropriate 54 
syringe size was defined as ‘the next largest syringe size to the volume to be measured’, 55 
e.g. a 5 mL syringe should be used to measure 3.2 mL of solution. 56 
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 57 
Accuracy of morphine infusions 58 
Over a 5 week period, nurses were asked to retain morphine syringes containing residual 59 
unused morphine solution from N/PCA morphine infusions administered to patients. All 60 
infusions were collected irrespective of whether preparation was observed by the researcher 61 
although these samples were identified. The infusions were analysed by the Pharmacy 62 
Quality Control laboratory. The morphine concentration in the infusions was measured 63 
based on the British Pharmacopoeia (BP) method for analysis of morphine sulphate injection 64 
[7] using a validated UV spectrophotometric assay covering the concentration range 65 
analysed in the current study. Samples were stored at room temperature and analysed 66 
within 4 weeks of collection. This storage was internally validated as morphine has been 67 
shown to be stable when stored in polypropylene syringes at room temperature for up to 6 68 
months, with loses of less than 3% over that period (unpublished data).  69 
Accuracy of infusions was defined as the percentage of the deviation from target 70 
concentration (label strength) within the pharmacopoeial limit for drug content of morphine 71 
sulphate injection, 92.5-107.5% [7].  72 
 73 
Data Analysis 74 
Data were analysed using Stata 11 (StataCrop, College Station, TX, USA). Descriptive 75 
statistics were performed on all data. Data are presented as number, percentage and mean 76 
± s.d., unless otherwise specified. The Chi-squared test was used to test for statistical 77 
significant (p<0.05), for categorical variables, between nurses (wards) and anaesthetists 78 
(theatres).  79 
 80 
Results 81 
Anaesthetists (n=28) and nurses (n=36) prepared 153 infusions for 128 children, (7.5 ± 5.6 82 
years and 27.4 ± 18.1 kg (mean ± s.d.), 65.3% male). The majority were prepared by 83 
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anaesthetists in paediatric theatres (64%), while the reminders were prepared by nurses in 84 
wards.  85 
Two strengths of morphine ampoule were available to prepare the infusions. Morphine 10 86 
mg in 1 mL was used to prepare all 98 infusions prepared in theatres, compared to only 16 87 
of the 55 infusions prepared on the wards, where 60 mg in 2 mL ampoules were used for 39 88 
infusions. Various methods to mix drug with diluent were identified (online appendix 1 shows 89 
the preparation methods followed by HCPs). Mean time for preparation in theatres, 10.5 min, 90 
was four minutes less than in wards. A variety of omissions or errors were identified, 91 
categorised as relating to the preparation or administration of the infusion and their 92 
frequency was recorded (Table 1). A significantly higher rate of error or non-compliance with 93 
good clinical practice was observed in the theatre setting for most types of errors, e.g. 94 
aseptic technique for IV drug preparation was not followed (15.3% vs. 1.8%), e.g. avoiding 95 
touching syringe-tip/needle, put down syringe attached to an unsheathed needle, no 96 
independent dose calculation checks (82.6% vs. 12.7%) and use of inappropriate syringe 97 
size for the volume to be measured (67.3% vs. 16.4%, p<0.001).  98 
 99 
‘Insert Table 1 here’ 100 
 101 
Although no calculation errors were identified, incorrect volume was withdrawn in many 102 
instances. The entire content of the morphine ampoule (10 mg/mL) including overage i.e. 103 
volume in excess of the nominal content (e.g. ampoule labelled as 10 mg/mL 1 mL ampoule, 104 
but contents actually closer to 11 mg in 1.1 mL) was withdrawn without measuring using 60 105 
mL syringes in 52 (53.1%) of the infusions made in theatres, compared to 2 infusions (3.6%) 106 
made on the wards. In some cases, the total volume was made up with the contents of 107 
whole ampoules plus an extra fraction measured in a syringe, e.g. 2.3 mL measured using 108 
the entire content of 2 ampoules plus 0.3 mL measured in a syringe. Errors were also 109 
observed in the final volume, i.e. volume was more or less than 50 mL (target volume), by at 110 
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least one graduation line in syringe, of the infusion in around one third of the cases in both 111 
theatres and wards. 112 
 113 
The “purge” function (running the pump mechanism before connecting to the patient’s 114 
cannula to ensure that the pump’s driver has engaged the syringe plunger and that the line 115 
is primed) was not used in a majority of administrations made in theatres and wards (Table 116 
1). In preparations where the purge function of the infusion pump was not used, between 0.3 117 
mL – 2.5 mL of infusion fluid was required to prime the system, despite the IV giving set 118 
being primed manually before the syringe was placed into pump syringe drive. However, in 119 
four instances in theatre (4.2%, 4/94), the anaesthetist administered a bolus dose via the 120 
pump once it was connected to the patient’s cannula as an alternative to purging.   121 
 122 
Accuracy of morphine infusions 123 
A total of 78 syringes (theatres 35, wards 43) containing unused morphine infusion were 124 
collected, of which 23 had been observed during preparation (theatres 14, wards 9). More 125 
than half (61.5%) of these infusions (48/78) had concentrations outside the BP limit for drug 126 
content (theatre 31; ward 17). A furthermore, ten infusions deviated by more than 20% 127 
(theatres 9, wards 1, p<0.001), (Figure 1), and one deviated by 100% (theatre).  128 
 129 
‘Insert Fig. 1 here’ 130 
 131 
Sixteen of the infusions found to be outside the BP limit were observed during preparation), 132 
(Table 2). The infusions prepared in theatre showed drug content deviations up to 26.7% 133 
while maximum deviation of infusions prepared in ward was 14.4%, (Table 2). The whole 134 
content of the drug ampoule, including the overage was drawn up in 8 of the 10 infusions 135 
prepared in theatre. This practice was not observed in the wards. The syringe size used to 136 
withdraw the required amount of drug from ampoule was inappropriate in 10 of the 16 137 
infusions (theatre 7, ward 3). In theatre, a 60 mL syringe was used to withdraw both drug 138 
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and diluent in 6 preparations. In all of these 6 preparations the entire content of ampoules 139 
was withdrawn directly into the infusion without measuring the volume. In two cases, part 140 
ampoules were required to complete the total volume and the additional volume from a part 141 
ampoule was measured and added separately.  142 
‘Insert Table 2 here’ 143 
 144 
Discussion 145 
This study is unique in combining observational assessment of paediatric infusion 146 
preparation in practice with drug content analysis of the prepared product. The results 147 
showed that preparation procedures for individualised infusions are not standardised and 148 
identified significant differences in practice between different clinical settings; theatres 149 
(anaesthetists) and wards (nurses). This resulted in children receiving morphine doses 150 
significantly higher or lower than those prescribed. Inaccuracy of intravenous infusions 151 
prepared in clinical settings has been previously reported in paediatric studies of continuous 152 
infusions [8-9]. The study was undertaken in a single hospital, and infusions prepared for 153 
emergency cases were not included. However, the findings from this study are likely to be 154 
generalisable as similar errors during preparation have been reported in other countries for 155 
infusions prepared on wards [8,10].  156 
 157 
The deviations from the prescribed dose identified in this study could potentially put children 158 
at risk of side effects, e.g. respiratory depression [11]; or change the prescriber’s views of 159 
the child’s clinical management because the child may be perceived as requiring more or 160 
less analgesia because the morphine concentration was inaccurate. Inaccuracy of volume 161 
measurement, or no measurement was one factor associated with infusions which deviated 162 
from the label strength. Another factor was failure to select the appropriate syringe size to 163 
withdraw the drug accurately from an ampoule. Sometimes the same syringe was used to 164 
draw up the drug and then the diluent; meaning that the drug retained in the dead space of 165 
the syringe will also be transferred to the product, resulting in an overdose. Understanding 166 
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the impact of drug retained in the dead space is important in children as significant overdose 167 
of drugs has been reported [12]. Disregard of the ampoule excess volume (overage) could 168 
be one of the contributing factors of greater infusion concentration deviation in theatres. This 169 
is consistent with outcome of the focus group we conducted with the HCPs where 170 
participants, mainly anaesthetists, explained their confusion about the exact volume of 171 
morphine solution in an ampoule and reported their practice of withdrawing the entire 172 
ampoule contents including the overage [13].  173 
 174 
Another potential cause of the deviations in morphine concentration was the difficulty of 175 
drawing up small drug volumes accurately and diluting up to 500 times for preparation of the 176 
infusions. The use of morphine 30 mg/mL led to measurements of very small volumes, thus 177 
the use of 10 mg/mL (a less concentrated product) would be recommended to improve 178 
accuracy. There is a lack of standardisation for preparation of infusions that needs to be 179 
addressed through staff familiarisation with good practice through training and protocols.  180 
 181 
This study provides a clear imperative to improve current practice for N/PCA, ideally through 182 
removal of the complex preparation which is prone to error. Potential solutions include 183 
standardisation of morphine concentrations for N/PCA use and/or performing bulk 184 
manufacture of ‘ready-to-use’ infusions in a quality-controlled environment. Using 185 
standardised concentrations in conjunction with advanced infusion apparatus has been 186 
reported to reduce errors. A study in children identified that the number of reported errors 187 
associated with continuous medication infusions was reduced by 73% following 188 
implementation of standard drug concentrations solutions administered using advanced 189 
safety pumps with inbuilt ‘drug libraries’ and default settings to facilitate  pump programming 190 
[14]. 191 
Less technical solutions include interventions to increase knowledge on the use of correct 192 
syringe size and raise awareness of overage in ampoules. 193 
 194 
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Conclusions 195 
This study identified that HCPs use a variety of techniques and manipulations when 196 
preparing IV infusions of morphine N/PCA for children, which includes practices leading to 197 
medication errors. A lack of understanding about the overage in ampoules, together with the 198 
challenge of selecting one or more syringe of the correct size, raises concern about the 199 
accuracy of the morphine infusions. The difficulty of drawing up very small drug volumes and 200 
combining these in large diluent volumes makes this practice error prone and inaccurate. 201 
Training and standardisation to improve the accuracy and promote safer provision of these 202 
infusions should be developed.  203 
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Figure 1. Deviation from the label strength of morphine concentrations in the 272 
individual 50 mL syringes prepared by healthcare professionals in theatres and wards 273 
 274 
The red lines show the target concentration within the British Pharmacopoeia acceptable limits of 275 
±7.5% and which data fall outside these limits. 276 
 277 
 278 
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Table 1. Number and percentage of various types of errors identified during observations 279 
 Theatres N=98 
Wards 
N=55 p- value 
Total 
N=153 
Preparation time; mean (±sd) 10.5 (±3.3) 14.5 (±4.0) <0.001 11.9 (±4.1) 
Incorrect preparation technique; n(%): 
Drug dose calculation was not checked by second person before 
preparation* 
81 (82.6) 7 (12.7) <0.001 88 (57.5) 
No double checking of volume withdrawn from ampoule by second person 58 (59.2) 12 (21.8) <0.001 70 (45.8) 
Aseptic technique (i.e. non-touch technique) not followed in preparing IV 
infusion, e.g. avoiding touching syringe-tip/needle.   
15 (15.3) 1 (1.8) <0.01 16 (10.5) 
No decontamination of ampoules  98 (100) 55 (100) - 153 (100) 
Wrong diluent† 0 1 (1.8) 0.180 1 (0.7) 
Wrong syringe size used to withdraw drug amount (in mL) from its ampoule; 66 (67.3) 9 (16.4) <0.001 75 (49.0) 
Prescribed dose (in mL); n(%)††:  
0.3 - 0.9 
 
4 (6.1) 0 
  
4 (5.5) 
1 - 1.9 11 (16.7) 1 (14.3)  12 (16.4) 
2 - 2.9 12 (18.2) 2 (28.6)  14 (19.2) 
3 - 3.9 10 (15.2) 0  10 (13.7) 
4 - 5 29 (43.9) 4 (57.1)  33 (45.2) 
Mixture was not mixed properly  58 (59.2) 19 (34.5) <0.01 77 (50.3) 
Air bubbles not expelled from syringe 1 (1%) 1 (1.8) 0.677 2 (1.3) 
Final volume not correct (> or <50mls) 38 (38.8) 17 (30.9) 0.331 55 (35.9) 
Final volume >50 mL 36 (36.7) 15 (27.3) 0.234 51 (33.3) 
Final volume not *checked by second person 88 (98.9) 51 (27.3) <0.001 139 (90.8) 
No gloves used during preparation 82 (83.7) 0 <0.001 82 (53.6) 
Incorrect administration techniques; n(%): 
IV giving set not primed  0 1 (1.8) 0.180 1 (0.7) 
No purging of the pump 94 (95.9) 51 (92.7) 0.584 145 (94.8) 
No flushing of IV access (cannula) before connecting the new IV set 98 (100)** 45 (81.9) <0.001 143 (93.5) 
No alcohol swab for IV access (cannula) before connecting IV giving set 98 (100) 18 (32.7) <0.001 116 (75.8) 
Patient identification not checked na** 9 (16.4) - 9 (5.9) 
No double checking of prescription against pump programme 4 (4.1) 30 (54.5) <0.001 34 (22.2) 
*according to hospital IV preparation protocol and nurse training programme, **na=not applicable, N/PCA IV infusion was prepared at the same time the 280 
patient in theatre, †near miss error (selecting wrong diluent glucose 5% instead of NaCL 0.9%) which was on prescription), ††percentage was calculated 281 
based on total number of preparations with wrong syringe size used in theatre (66), ward (7) and total cohort (73). 282 
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Table 2. Observed errors on preparation of morphine infusions deviating from the label strength by ±7.5% (i.e. outside British 283 
Pharmacopoeia limit) 284 
Location 
Target 
infusion 
concentration 
(mg in 50 mL) 
Ampoule 
strength used 
for preparation 
(mg/mL) 
Volume 
required 
(mL) 
Actual volume withdrawn 
(mL) 
Entire content 
of ampoule 
used 
Syringe size 
used to 
withdraw volume 
(mL) 
Correct 
syringe 
size 
Deviatio
n (%) 
Theatres 8 10  0.8 0.8 no 1 yes +17.5 
8 10  0.8 0.8 no 1 yes +10.1 
9 10  0.9 not measured  yes 10† no +18.5 
27 10  2.7 not measured  yes 60 + 1* no +24.5 
29 10  2.9 not measured  yes 60 + 1* no +9.5 
30 10  3 not measured  yes 5 yes +14.9 
50 10  5 not measured  yes 60 no +26.7 
50 10  5 not measured  yes 60 no +12.7 
50 10  5 not measured  yes 60 no +20.3 
50 10  5 not measured  yes 60 no +14.0 
Wards 10 10  1 1 no 3 no +14.4 
7 30  0.233 0.24 no 1 yes +11.7 
22 30  0.733 0.74 no 1 yes +8.5 
23 30  0.766 0.77 no 1 yes +12.0 
26 30  0.866 ~0.87 no 3 no +12.3 
27 30  0.9 1 no 3 no +10.7 
†The whole content of the ampoule was withdrawn using 10 mL syringe then diluted up to 10 mL, and then 9 mL of the solution was added into the 60 mL 
syringe then volume completed to 50 mL with diluent. *not measured, i.e. whole ampoule’s content was withdrawn. 
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Online appendix 1. Preparation methods followed by healthcare professionals  
Mixing method description Frequency n (%) 
1. Draw diluent amount first into 60-mL syringe, 2. Draw drug amount from ampoule into another syringe using different needle,  
3. Add amount of drug into diluent syringe.   81 (52.9) 
1. Draw up diluent amount first into 60-mL syringe, 2. Draw up the whole content of drug ampoule directly into diluent syringe using diluent 
needle.  
Example: Morphine  50mg in 50 mL of Sodium Chloride 0.9% w/v 
Draw up 45mL of diluent (normal saline) into 60-mL syringe, then draw up the whole content of 5 ampoules of the drug (concentration 
10mg/ml) directly into the 60ml-syringe using same needle of the diluent.  
21 (13.7) 
1. Draw diluent amount first into 60-mL syringe, 2. Add the whole content of drug ampoule into diluent syringe using same diluent needle  
3. Using 10-mL syringe draw up whole content of another drug ampoule, then diluent into 10ml with normal saline, then add the required 
amount of the drug into diluent syringe (60-mL syringe) using diluent needle.  
Example: Morphine  25 mg in 50 mL of Sodium Chloride 0.9% w/v 
Draw up 43 mL of diluent (normal saline), then draw up the whole contents of 2 ampoules (10 mg/mL) of the drug directly into diluent syringe 
(60mL-size), then dilute the whole content of a 3rd ampoule of the drug (10mg/ml) into 10 mL normal saline. Resultant concentration 10 mg/10 
mL, then, using diluent needle take 5 mL (5 mg) of this solution and add it into diluent syringe. 
9 (5.9) 
1. First draw up the whole content of drug from ampoule into 60-mL syringe, 2. Then add diluent to complete volume up to 50 mL.  19 (12.4) 
1. Draw up amount of diluent first into 60-mL syringe, 2. Draw up the whole contents of ampoule of drug directly into diluent syringe (60 mL-
size) 
3. Using 1 mL-syringe draw up the remaining amount of from another ampoule and added it into diluent syringe. 
Example: Morphine  36 mg in 50 mL of Sodium Chloride 0.9% w/v 
Draw up ~47mL of diluent (normal saline) then draw up the whole content of 3 ampoules of the drug directly into 60 mL-syringe, then using 3 
mL-syringe to draw up 0.6 mL of the drug from the 4th ampoule and add it into 60 mL syringe. 
10 (6.5) 
1. Draw up content of whole ampoule into 60-mL syringe, 2. Using 10-mL syringe dilute the whole content of another ampoule (10 mg/mL) of 
the drug into 10 mL normal saline, then add the required amount into the 60-mL syringe 
3. Complete the volume up to 50 mL with normal saline. 
Example: Morphine 34 mg in 50 mL of Sodium Chloride 0.9% w/v 
First draw up the contents of 3 ampoules (10 mg/mL)of drug directly into diluent 60 mL-syringe, then dilute  the whole content of the 4th 
ampoule of the drug into 10 mL normal saline then add 4 mL (4mg) of this solution into 60-mL syringe, then complete the volume up to 50ml 
with normal saline.  
8 (5.2) 
1. Draw up amount of diluent first into 60-mL syringe, 2. Dilute the content of one drug ampoule (concentration 10mg/1mL) in 10 mL of normal 
saline, then added required amount to the into diluent syringe (new needle used) 
Example: Morphine  7 mg in 50 mL of Sodium Chloride 0.9% w/v 
First draw up 43 mL of normal saline (diluent) into 60-mL syringe, then using 10-mL syringe dilute the whole content of drug ampoule (10 
mg/mL) into 10 mL normal saline, then add 7 mL (7 mg) of this solution into the diluent syringe. 
5 (3.3) 
14 
 
 
 
 
 
 
 
